Carol Judkins

A Safety and Feasibility Study of an Allogeneic Colon Cancer Cell Vaccine Administered with a Granulocyte–Macrophage Colony Stimulating Factor–Producing Bystander Cell Line in Patients with Metastatic Colorectal Cancer

E. Jaffee, B. Edil, D. Pardoll, 2014, Annals of Surgical Oncology.

A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint

G. Rosner, N. Ahuja, E. Jaffee, 2021, Clinical Epigenetics.

Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma

M. Makary, J. Cameron, E. Jaffee, 2020, Clinical Cancer Research.

Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017

Vikesh K. Singh, J. Cameron, A. Zaheer, 2020, Cancer letters.

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Hao Wang, E. Jaffee, W. Burns, 2023, Nature communications.